MOLLY ELLIS: Open Payments
NPI 1811430473 · CHILDERSBURG, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,393 in 180 payments from 24 companies in 2025. Trend: 2023 $3,150 · 2024 $3,551 · 2025 $3,393
Food & beverage: $3,393
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 24 | $496 |
| ABBVIE INC. | 28 | $410 |
| AstraZeneca Pharmaceuticals LP | 15 | $380 |
| Novo Nordisk Inc | 19 | $351 |
| PFIZER INC. | 12 | $201 |
| GlaxoSmithKline, LLC. | 10 | $196 |
| Vanda Pharmaceuticals Inc. | 10 | $176 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $164 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $153 |
| Otsuka America Pharmaceutical, Inc. | 6 | $103 |
Products named: Kerendia, FARXIGA, TRELEGY ELLIPTA, FANAPT, NURTEC ODT, Ozempic, Wegovy, CAPLYTA.
Industry payments across AL — which companies pay providers there.
